Phase II Study of RAD001 Monotherapy in Patients With Unresectable Adenoid Cystic Carcinoma

被引：0
|
作者：
Kim, D. [1 ]
Shin, S. [2 ]
Kang, J. [3 ]
Cho, B. [4 ]
Kim, H. [5 ]
Jung, J. [6 ]
Park, K. [7 ]
Kwon, J. [8 ]
Hang, J. [9 ]
Bang, Y. [1 ]
机构：
[1] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea
[2] Kosin Univ, Gospel Hosp, Dept Internal Med, Pusan, South Korea
[3] Catholic Univ, Dept Internal Med, Seoul St Marys Hosp, Seoul, South Korea
[4] Yonsei Canc Ctr, Dept Internal Med, Seoul, South Korea
[5] Vet Hosp, Dept Internal Med, Seoul, South Korea
[6] Pusan Natl Univ Hosp, Dept Internal Med, Pusan, South Korea
[7] Keimyung Univ, Dept Internal Med, Dongsan Med Ctr, Taegu, South Korea
[8] Hallym Univ, Med Ctr, Dept Internal Med, Seoul, South Korea
[9] Natl Canc Ctr, Ctr Lung Canc, Ilsan, South Korea
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72144-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S544 / S544
页数：1
相关论文
共 50 条
  • [41] Phase II trial of the oral mTOR inhibitor everolimus (RAD001) for patients with relapsed or refractory lymphoma
    Johnston, P. B.
    Ansell, S. M.
    Colgan, J. P.
    Habermann, T. M.
    Inwards, D. J.
    Markovic, S. N.
    Micallef, I. N.
    Porrata, L. F.
    LaPlant, B. R.
    Geyer, S. M.
    Witzig, T. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] Phase III Data in neuroendocrine Tumors show: RAD001 as Monotherapy and in Combination with Sandostatin© LAR© effectively
    Roth, Irene
    VISZERALMEDIZIN, 2010, 26 (04): : 290 - 290
  • [43] Phase II study of sunitinib in patients (pts) with progressive metastatic adenoid cystic carcinoma (ACC)
    Hotte, S. J.
    Chen, E. X.
    Hirte, H. W.
    Moretto, P.
    Turner, S.
    Chin, S. F.
    Wang, L.
    MacAlpine, K.
    Siu, L. L.
    EJC SUPPLEMENTS, 2008, 6 (12): : 65 - 65
  • [44] Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors
    Jennifer A. Chan
    Robert J. Mayer
    Nadine Jackson
    Paige Malinowski
    Eileen Regan
    Matthew H. Kulke
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1241 - 1246
  • [45] A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma
    Ho, A. L.
    Dunn, L.
    Sherman, E. J.
    Fury, M. G.
    Baxi, S. S.
    Chandramohan, R.
    Dogan, S.
    Morris, L. G. T.
    Cullen, G. D.
    Haque, S.
    Sima, C. S.
    Ni, A.
    Antonescu, C. R.
    Katabi, N.
    Pfister, D. G.
    ANNALS OF ONCOLOGY, 2016, 27 (10) : 1902 - 1908
  • [46] Prediction of response to RAD001 (everolimus) in patients with metastatic renal cell carcinoma
    Seidel, C.
    Fenner, M.
    Merseburger, A.
    Heuser, M.
    Ganser, A.
    Gruenwald, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [47] A phase II study of lenvatinib in patients with progressive, recurrent/metastatic adenoid cystic carcinoma.
    Tchekmedyian, Vatche
    Sherman, Eric Jeffrey
    Dunn, Lara
    Tran, Crystal
    Katabi, Nora
    Ni, Ai
    Haque, Sofia
    Pfister, David G.
    Ho, Alan Loh
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [48] Phase II study of RAD001 (everolimus) in previously treated small cell lung cancer (SCLC)
    Kotsakis, Athanasios
    Tarhini, Ahmad
    Petro, Daniel
    Flaugh, Rick
    Vallabhaneni, Geetha
    Belani, Chandra
    Friedland, David
    Argiris, Athanassios
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S464 - S464
  • [49] Efficacy of RAD001/carboplatin in triple-negative metastatic breast cancer: A phase II study
    Singh, Jasmeet Chadha
    Volm, Matthew
    Novik, Yelena
    Speyer, James L.
    Adams, Sylvia
    Omene, Coral Oghenerukevwe
    Meyers, Marleen Iva
    Smith, Julia Anne
    Schneider, Robert
    Formenti, Silvia
    Goldberg, Judith D.
    Li, Xiaochun
    Davis, Samantha
    Beardslee, Brian
    Tiersten, Amy
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [50] A Phase 1/2 Study of RAD001, a mTOR Inhibitor, In Patients with Myelofibrosis: Final Results
    Vannucchi, Alessandro M.
    Guglielmelli, Paola
    Lupo, Letizia
    Finazzi, Maria Chiara
    Tozzi, Lorenzo
    Biamonte, Flavia
    Masciulli, Arianna
    Susini, Maria Chiara
    Pancrazzi, Alessandro
    Finazzi, Guido
    Paratore, Simona
    Marchioli, Roberto
    Bosi, Alberto
    Barbui, Tiziano
    Rambaldi, Alessandro
    Barosi, Giovanni
    BLOOD, 2010, 116 (21) : 143 - 143
12345